Generic name:respiratory syncytial virus vaccine, adjuvanted(rsv vaccine pref3, recombinant systemic) Dosage form:suspension for intramuscular injection Drug class:Viral vaccines Medically reviewed byMelisa Puckey, BPharm. Last updated on Jun 17, 2024. ...
et al. Respiratory syncytial virus prefusion F protein vaccine in older adults[J]. New England Jo...
RSVpreF(RSV preF-based Vaccine) RSV A Memphis 37 RSVΔNS2/Δ1313/I1314L Vaccine ,RSV 6120/ΔNS2/1030s Vaccine,RSV 276 Vaccine Ad26.RSV.preF-based Vaccine RSV vaccine MV-012-968 mRNA-1345 RSV vaccine formulation 1,RSV vaccine formulation 2 Recombinant Respiratory Syncytial Virus Vaccine (BAR...
But the hunt for vaccines could now be poised to deliver two subunit vaccines that train the immune system using the recombinant prefu-sion F (preF) antigen, a key form of the viral fusion protein that the virus uses to enter human cells. GSK'sRSVPreF3, also called GSK3844766A, pairs...
Respiratory syncytial virus vaccine recombinant, adjuvanted (proposed trade name: Arexvy). FDA. March 1, 2023. Accessed May 15, 2023. https://www.fda.gov/media/165622/download 26. Guillain-Barr. syndrome. National Institute of Neurological Disorders and Stroke. Reviewed March 8, 2023. Accessed...
et al. Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies. PLoS ONE 9, e100392 (2014). ...
Additionally, only one vaccine modality—the recombinant AdC68 vector expressing designer pre-F glycoproteins—was evaluated, which may not represent outcomes with other vaccine platforms, such as recombinant protein or mRNA vaccines. Future studies comparing different vaccine modalities head-to-head will...
The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate. PMID: 36602367 A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protect...
Herein, we describe its application to conformationally stabilize a viral fusion protein-based recombinant subunit vaccine, which in turn improves its potency, shelf-life, and cold-chain requirements. In addition to our stabilized RSV F protein, DT-preF, we are currently applying the technology to...
DS-Cav1, SC-TM, and DS2 are distinct designer pre-fusion F proteins (pre-F) of respiratory syncytial virus (RSV) developed for vaccines. However, their immunogenicity has not been directly compared. In this study, we generated three recombinant vaccines